Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Insulin signaling pathway | R-HSA-74752 | map04910 | gibberellic acid | 92766 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | gibberellic acid | 92766 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | gibberellic acid | 92766 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | gibberellic acid | 92766 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | gibberellic acid | 92766 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | apramycin | 3081545 | drug-path |
Gap junction | R-HSA-190861 | map04540 | apramycin | 3081545 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tocainide | 38945 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tocainide | 38945 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | tocainide | 38945 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | tocainide | 38945 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | Prestwick-984 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-984 | None | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | zuclopenthixol | 5311507 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | zuclopenthixol | 5311507 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | zuclopenthixol | 5311507 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | zuclopenthixol | 5311507 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | zuclopenthixol | 5311507 | drug-path |
Shigellosis | 0 | map05131 | zuclopenthixol | 5311507 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | zuclopenthixol | 5311507 | drug-path |